This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone September quarter revenue rises 39.7%, profit rises 29.4%
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.4 pts more than Nifty Microcap 250 and 8.0 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
For the standalone quarter ended September 30, 2026, revenue from operations rose 39.7% to Rs 2,587.48 lakh from Rs 1,852.75 lakh a year earlier; profit after tax rose 29.4% to Rs 370.44 lakh from Rs 286.29 lakh. For the standalone half year ended September 30, 2026, revenue was Rs 4,683.41 lakh and net profit Rs 706.22 lakh. The board approved the unaudited results; prior figures were regrouped or reclassified, and the auditor found no material issue.
Strong revenue and profit growth may support the stock, but higher inventory and receivables and weaker half-year cash flow are risks.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹25.87 Cr | ₹18.53 Cr | +39.7% |
| Operating profit | ₹4.19 Cr | ₹3.09 Cr | +35.5% |
| Profit after tax | ₹3.70 Cr | ₹2.86 Cr | +29.4% |
| EBITDA margin | 17.3% | 18.2% | −0.9 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.